High doses drop after moves to curb overprescribing

Patients have been shifting to lower dose PPIs following PBS listing changes, review reveals, but more investigation is needed The Drug Utilisation Sub-Committee (DUSC) of the PBAC has found positive trends in the use of PBS-listed proton pump inhibitor (PPI) medicines following listing changes made to help curb overprescribing. On 1 May 2019, changes were